<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1662-4548</issn>
<issn pub-type="epub">1662-453X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26578866</article-id>
<article-id pub-id-type="pmc">4630302</article-id>
<article-id pub-id-type="doi">10.3389/fnins.2015.00406</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Brain-specific transcriptional regulator T-brain-1 controls brain wiring and neuronal activity in autism spectrum disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Tzyy-Nan</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/285846/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hsueh</surname>
<given-names>Yi-Ping</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/1983/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff>
<institution>Institute of Molecular Biology, Academia Sinica</institution>
<country>Taipei, Taiwan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Gul Dolen, Johns Hopkins University, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Marc Fuccillo, University of Pennsylvania, USA; Mollie Meffert, Johns Hopkins School of Medicine, USA</p>
</fn>
<corresp id="fn001">*Correspondence: Yi-Ping Hsueh <email xlink:type="simple">yph@gate.sinica.edu.tw</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Systems Biology, a section of the journal Frontiers in Neuroscience</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="collection">
<year>2015</year>
</pub-date>
<volume>9</volume>
<elocation-id>406</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>4</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>12</day>
<month>10</month>
<year>2015</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2015 Huang and Hsueh.</copyright-statement>
<copyright-year>2015</copyright-year>
<copyright-holder>Huang and Hsueh</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p><italic>T-brain-1</italic> (<italic>TBR1</italic>) is a brain-specific T-box transcription factor. In 1995, <italic>Tbr1</italic> was first identified from a subtractive hybridization that compared mouse embryonic and adult telencephalons. Previous studies of <italic>Tbr1</italic><sup>−∕−</sup> mice have indicated critical roles for TBR1 in the development of the cerebral cortex, amygdala, and olfactory bulb. Neuronal migration and axonal projection are two important developmental features controlled by TBR1. Recently, recurrent <italic>de novo</italic> disruptive mutations in the <italic>TBR1</italic> gene have been found in patients with autism spectrum disorders (ASDs). Human genetic studies have identified <italic>TBR1</italic> as a high-confidence risk factor for ASDs. Because only one allele of the TBR1 gene is mutated in these patients, <italic>Tbr1</italic><sup>+∕−</sup> mice serve as a good genetic mouse model to explore the mechanism by which <italic>de novo TBR1</italic> mutation leads to ASDs. Although neuronal migration and axonal projection defects of cerebral cortex are the most prominent phenotypes in <italic>Tbr1</italic><sup>−∕−</sup> mice, these features are not found in <italic>Tbr1</italic><sup>+∕−</sup> mice. Instead, inter- and intra-amygdalar axonal projections and NMDAR expression and activity in amygdala are particularly susceptible to <italic>Tbr1</italic> haploinsufficiency. The studies indicated that both abnormal brain wiring (abnormal amygdalar connections) and excitation/inhibition imbalance (NMDAR hypoactivity), two prominent models for ASD etiology, are present in <italic>Tbr1</italic><sup>+∕−</sup> mice. Moreover, calcium/calmodulin-dependent serine protein kinase (CASK) was found to interact with TBR1. The CASK–TBR1 complex had been shown to directly bind the promoter of the <italic>Grin2b</italic> gene, which is also known as <italic>Nmdar2b</italic>, and upregulate <italic>Grin2b</italic> expression. This molecular function of TBR1 provides an explanation for NMDAR hypoactivity in <italic>Tbr1</italic><sup>+∕−</sup> mice. In addition to <italic>Grin2b</italic>, cell adhesion molecules—including <italic>Ntng1, Cdh8</italic>, and <italic>Cntn2</italic>—are also regulated by TBR1 to control axonal projections of amygdala. Taken together, the studies of <italic>Tbr1</italic> provide an integrated picture of ASD etiology at the cellular and circuit levels.</p>
</abstract>
<kwd-group>
<kwd>amygdala</kwd>
<kwd>axonal projection</kwd>
<kwd>autism</kwd>
<kwd>cerebral cortex</kwd>
<kwd>intellectual disability</kwd>
<kwd>neural circuit</kwd>
<kwd>neurodevelopmental disorders</kwd>
<kwd>TBR1</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Academia Sinica<named-content content-type="fundref-id">10.13039/501100001869</named-content></funding-source>
<award-id rid="cn001">AS-103-TP-B05</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Ministry of Science and Technology<named-content content-type="fundref-id">10.13039/100007225</named-content></funding-source>
<award-id rid="cn002">103-2321-B-001-002</award-id>
<award-id rid="cn002">103-2321-B-001-018</award-id>
<award-id rid="cn002">104-2321-B-001-050</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="4"></fig-count>
<table-count count="6"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="60"></ref-count>
<page-count count="13"></page-count>
<word-count count="9445"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Autism spectrum disorders (ASDs) are heterogeneous and highly heritable neuropsychiatric disorders. Hundreds of genes with <italic>de novo</italic> copy-number variations or <italic>de novo</italic> point mutations have been identified in thousands of patients with ASDs (Gilman et al., <xref ref-type="bibr" rid="B18">2011</xref>; Neale et al., <xref ref-type="bibr" rid="B42">2012</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>,<xref ref-type="bibr" rid="B46">b</xref>; De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; Iossifov et al., <xref ref-type="bibr" rid="B29">2014</xref>). Although this variety of ASD-associated genes reflects the high heterogeneity of ASDs, ~26 high-confidence risk genes for ASDs have been summarized from large scale whole-exome sequencing (O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>; De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; Table <xref ref-type="table" rid="T1">1</xref>). Among these high-confidence risk genes, 11 encode either transcription factors or chromatin remodeling factors, indicating that the dysregulation of gene expression is a common pathogenic mechanism for ASDs (Table <xref ref-type="table" rid="T1">1</xref>). To date, <italic>T-BRAIN-1</italic> (<italic>TBR-1</italic>) is the best studied transcription regulator among the high-confidence risk genes for ASDs. In this review, we summarize the physiological functions of TBR1 and the currently understood mechanisms by which <italic>TBR1</italic> mutations cause ASDs. Based on the data accumulated from the mouse model, we suggest that abnormal brain wiring and reduced neuronal activity in the amygdala are the primary causes for <italic>TBR1</italic>-dependent ASDs.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>High-confidence risk factors for ASDs</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene symbol</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene Name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Molecular function</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ADNP</td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity-dependent neuroprotector homeobox</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ANK2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ankyrin 2, neuronal</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cytoskeleton interactor</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ARID1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">AT rich interactive domain 1B (SWI1-like)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASH1L</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ash1 (absent, small, or homeotic)-like (Drosophila)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">ASXL3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Additional sex combs like transcriptional regulator 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">BCL11A</td>
<td align="left" colspan="1" rowspan="1" valign="top">B-cell CLL/lymphoma 11A (zinc finger protein)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CACNA2D3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Calcium channel, voltage-dependent, alpha 2/delta subunit 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ion channel</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CHD8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chromodomain helicase DNA binding protein 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CTTNBP2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cortactin binding protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cytoskeleton interactor</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CUL3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cullin 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein degradation</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">DYRK1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GABRB3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Gamma-aminobutyric acid (GABA) A receptor, beta 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ion channel</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">GRIN2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate receptor, ionotropic, N-methyl D-aspartate 2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ion channel</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">KATNAL2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Katanin p60 subunit A-like 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cytoskeleton interactor</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MIB1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mindbomb E3 ubiquitin protein ligase 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein degradation</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">MLL3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lysine (K)-specific methyltransferase 2C</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">POGZ</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pogo transposable element with ZNF domain</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enzyme</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">PTEN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phosphatase and tensin homolog</td>
<td align="left" colspan="1" rowspan="1" valign="top">Phosphatase</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">RELN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reelin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SCN2A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sodium channel, voltage-gated, type II, alpha subunit</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ion channel</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SETD5</td>
<td align="left" colspan="1" rowspan="1" valign="top">SET domain containing 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SHANK3</td>
<td align="left" colspan="1" rowspan="1" valign="top">SH3 and multiple ankyrin repeat domains 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Postsynaptic adaptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SUV420H1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Suppressor of variegation 4–20 homolog 1 (Drosophila)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SYNGAP1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic Ras GTPase activating protein 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; SFARI</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TBL1XR1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transducin (beta)-like 1 X-linked receptor 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">TBR1</td>
<td align="left" colspan="1" rowspan="1" valign="top">T-box, brain, 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription regulator</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>; SFARI</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2">
<title>Identification of TBR1 in the regulation of brain development</title>
<p>TBR1 contains a T-box DNA binding domain (Figure <xref ref-type="fig" rid="F1">1</xref>) and belongs to the T-box transcription factor family (Papaioannou, <xref ref-type="bibr" rid="B48">2014</xref>). Twenty years ago, Dr. John Rubenstein's laboratory first identified <italic>Tbr1</italic> from a subtractive hybridization screen using cDNA libraries made from mouse embryonic day 14.5 (E14.5) and adult telencephalons (Bulfone et al., <xref ref-type="bibr" rid="B5">1995</xref>). <italic>Tbr1</italic> mRNA levels were approximately 10-fold higher in E14.5 telencephalons than in adult telencephalons (Bulfone et al., <xref ref-type="bibr" rid="B5">1995</xref>), suggesting a role for TBR1 in brain development. <italic>In situ</italic> hybridization and immunofluorescence staining indicate that <italic>Tbr1</italic> is expressed in the postmitotic neurons of the cerebral cortex, hippocampus, olfactory bulb and amygdala at the embryonic stages (Bulfone et al., <xref ref-type="bibr" rid="B5">1995</xref>, <xref ref-type="bibr" rid="B6">1998</xref>; Remedios et al., <xref ref-type="bibr" rid="B49">2007</xref>; Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). Using markers of projection neurons, including glutamate and CaMKII, TBR1 has been found to be further restricted to the projection neurons of the cerebral cortex, amygdala and olfactory bulb (Bulfone et al., <xref ref-type="bibr" rid="B6">1998</xref>; Hevner et al., <xref ref-type="bibr" rid="B22">2001</xref>; Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). In the cerebral cortex, layer 6 neurons express the highest levels of TBR1. Projection neurons in the remaining layers also express TBR1, though the expression levels are lower (Hevner et al., <xref ref-type="bibr" rid="B22">2001</xref>). In the amygdala, TBR1 is only expressed in the projection neurons of the lateral and basal amygdala (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). These studies clearly show that TBR1 is a projection neuron-specific T-box factor highly enriched in embryonic telencephalons.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Schematic domain structure of TBR1 and identified mutations in patients with ASDs</bold>. The T-box DNA binding domain extends from amino acid (aa) residue 203–397. The predicted aa residues for DNA binding and dimerization based on the T-box structure of Brachyury (T protein) are also indicated and labeled with red and green strips in the T-box. The positions of <italic>de novo</italic> mutations are labeled with red triangles; the positions of rare inherited mutations are labeled with blue triangles. The functions of the residues in the T-box are predicted based on comparison with the Brachury T-box (pfam00907: T-box, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=250216">http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=250216</ext-link>).</p>
</caption>
<graphic xlink:href="fnins-09-00406-g0001"></graphic>
</fig>
<p>Dr. John Rubenstein and colleagues generated <italic>Tbr1</italic><sup>−∕−</sup> mice to investigate the physiological function of <italic>Tbr1</italic> (Bulfone et al., <xref ref-type="bibr" rid="B6">1998</xref>; Hevner et al., <xref ref-type="bibr" rid="B22">2001</xref>). A homozygous deficiency of <italic>Tbr1</italic> results in neonatal lethality within 1–2 days after birth, indicating that <italic>Tbr1</italic> is essential for survival. Most projection neurons in the olfactory bulb, including mitral and tufted cells, and axonal output to the lateral olfactory tract are lost in <italic>Tbr1</italic><sup>−∕−</sup> mice (Bulfone et al., <xref ref-type="bibr" rid="B6">1998</xref>). In the cerebral cortex, the inside-out pattern of neuronal migration is completely disrupted, as the six-layer laminar structure of the cortex is disorganized. Moreover, the contralateral axonal projections of the cerebral cortex and both corticothalamic and thalamocortical axonal projections are also defective, since they end mid-way to their final destinations in <italic>Tbr1</italic><sup>−∕−</sup> mice (Hevner et al., <xref ref-type="bibr" rid="B22">2001</xref>). TBR1 is also required for neuronal migration in the amygdala. A portion of the dorsal pallium that migrates from the caudal telencephalon pole toward the rostral telencephalon forms the basal and lateral amygdala. In <italic>Tbr1</italic><sup>−∕−</sup> mice, this caudal-to-rostral migration is disrupted and thus impairs amygdala development (Remedios et al., <xref ref-type="bibr" rid="B49">2007</xref>). Although TBR1 is also expressed in the hippocampus, its importance in hippocampus development and function remains unclear.</p>
<p>Based on the studies using <italic>Tbr1</italic><sup>−∕−</sup> mice, it is clear that TBR1 is critical for development of projection neurons in the cerebral cortex, olfactory bulb and amygdala.</p>
</sec>
<sec id="s3">
<title>TBR1 downstream target genes</title>
<p>Target genes of the TBR1 transcription factor were first identified by searching a database using the target sequence of the T-box DNA binding domain (Hsueh et al., <xref ref-type="bibr" rid="B26">2000</xref>; Wang et al., <xref ref-type="bibr" rid="B56">2004a</xref>,<xref ref-type="bibr" rid="B58">c</xref>). Because members of the T-box protein family share a DNA binding sequence, this method cannot ensure that the target genes are specific for TBR1. Because TBR1 is neuron-specific, neuronal expression is the first criterion to further screen the TBR1 target genes identified from sequence analysis. Results of an electrophoretic mobility shift assay, chromatin immunoprecipitation and a luciferase reporter assay have shown that TBR1 directly binds to the promoters and regulates the promoter activity of <italic>Grin2b</italic> (<italic>Glutamate receptor, ionotropic, N-methyl-aspartate 2b</italic>, also known as <italic>Nmdar2b</italic>) and <italic>Reln</italic> (<italic>Reelin</italic>) (Hsueh et al., <xref ref-type="bibr" rid="B26">2000</xref>; Wang et al., <xref ref-type="bibr" rid="B56">2004a</xref>,<xref ref-type="bibr" rid="B58">c</xref>). Changes in RELN and NMDAR2B protein levels have also been confirmed in <italic>Tbr1</italic><sup>−∕−</sup> mice (Hevner et al., <xref ref-type="bibr" rid="B22">2001</xref>; Wang et al., <xref ref-type="bibr" rid="B58">2004c</xref>). Because <italic>Reln</italic> encodes an extracellular protein that is critical for neuronal migration (Martinez-Cerdeno and Noctor, <xref ref-type="bibr" rid="B37">2014</xref>; Ohshima, <xref ref-type="bibr" rid="B43">2014</xref>; Sekine et al., <xref ref-type="bibr" rid="B52">2014</xref>), regulation of <italic>Reln</italic> expression by TBR1 could explain the migration phenotype in <italic>Tbr1</italic><sup>−∕−</sup> mice. Regulation of <italic>Grin2b</italic> expression by TBR1 is critical for neuronal activation, which we discuss further in a later section.</p>
<p>Both our and Dr. Robert Hevner's laboratories independently applied microarray analyses to identify TBR1 downstream genes. Using E14.5 and P0.5 mouse brains, Dr. Hevner's laboratory focused on the arealization and lamination of the cerebral cortex (Bedogni et al., <xref ref-type="bibr" rid="B1">2010</xref>). <italic>Tbr1</italic> exhibits a high rostral and low caudal expression pattern in the cortex (Bulfone et al., <xref ref-type="bibr" rid="B5">1995</xref>). At both E14.5 and P0.5, a <italic>Tbr1</italic> deletion noticeably alters the expression of regional markers. In general, rostral genes are downregulated in <italic>Tbr1</italic><sup>−∕−</sup> brains, while caudal genes are upregulated. For cortical layer markers, most markers of layer 6, subplate and Cajal–Retzius cells exhibit noticeably reduced expression levels in <italic>Tbr1</italic><sup>−∕−</sup> brains. The majority of layer 2–5 markers are upregulated (Bedogni et al., <xref ref-type="bibr" rid="B1">2010</xref>). The markers of lamination and arealization whose expression levels are altered in <italic>Tbr1</italic><sup>−∕−</sup> brains are listed in Table <xref ref-type="table" rid="T2">2</xref>. These studies indicate that TBR1 is critical for controlling the neuronal specification of the cerebral cortex.</p>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p><bold><italic><bold>Tbr1</bold></italic> deletion alters expression of genes with layer- or region-specific distribution in the cerebral cortex</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene symbol<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Layer</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Region</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bhlhb5 (BHLHE22)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Basic helix-loop-helix family, member e22</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudomedial</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Calb2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Calbindin 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cajal–Retzius</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cdh8<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cadherin 8, type 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostral + caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cdh9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cadherin 9, type 2 (T1-cadherin)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostral</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cntn3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 3 (plasmacytoma associated)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cntn6<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 SCPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cplx3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Complexin 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cajal–Retzius</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Crim1<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cysteine rich transmembrane BMP regulator 1 (chordin-like)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 corticospinal motor neuron</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Crym</td>
<td align="left" colspan="1" rowspan="1" valign="top">Crystallin, mu</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 corticospinal motor neuron</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ctgf<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Connective tissue growth factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Subplate</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ctip2 (Bcl11b)</td>
<td align="left" colspan="1" rowspan="1" valign="top">B-cell CLL/lymphoma 11B (zinc finger protein)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 SCPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cux1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cut-like homeobox 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cux2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cut-like homeobox 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dkk3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dickkopf WNT signaling pathway inhibitor 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">CPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudomedial</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Drd1a<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dtx4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deltex 4, E3 ubiquitin ligase</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Etv1 (Er81)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ets variant 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Fezf2</td>
<td align="left" colspan="1" rowspan="1" valign="top">FEZ family zinc finger 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 SCPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Flrt3<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibronectin leucine rich transmembrane protein 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Foxp1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forkhead box P1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Foxp2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forkhead box P2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Inhba</td>
<td align="left" colspan="1" rowspan="1" valign="top">Inhibin, beta A</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4, CPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lhx5</td>
<td align="left" colspan="1" rowspan="1" valign="top">LIM homeobox 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cajal–Retzius</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Limch1</td>
<td align="left" colspan="1" rowspan="1" valign="top">LIM and calponin homology domains 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3, CPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mdga1</td>
<td align="left" colspan="1" rowspan="1" valign="top">MAM domain containing glycosylphosphatidylinositol anchor 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Mef2c</td>
<td align="left" colspan="1" rowspan="1" valign="top">Myocyte enhancer factor 2C</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nefm<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofilament, medium polypeptide</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nfe2l3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear factor, erythroid 2-like 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ngfr</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nerve growth factor receptor</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nhlh2<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Nescient helix loop helix 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cajal–Retzius</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Npy</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neuropeptide Y</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nr4a2 (Nurr1)<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear receptor subfamily 4, group A, member 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nr4a3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear receptor subfamily 4, group A, member 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nrgn<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurogranin</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nxph4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurexophilin 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Subplate</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Oma1</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMA1 zinc metallopeptidase</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 SCPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pcdh11x</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protocadherin 11 X-linked</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pcdh19</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protocadherin 19</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pcdh20</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protocadherin 20</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostral</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pcdh8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protocadherin 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pcp4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Purkinje cell protein 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pou3f2 (Brn-2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">POU class 3 homeobox 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pou3f3 (Brn-1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">POU class 3 homeobox 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ppp1r1b<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein phosphatase 1, regulatory (inhibitor) subunit 1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostral</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ptn</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pleiotrophin</td>
<td align="left" colspan="1" rowspan="1" valign="top">CPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ptprz1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein tyrosine phosphatase, receptor-type, Z polypeptide 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudal</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pvrl3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Poliovirus receptor-related 3</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3, CPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">Caudomedial</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Reln<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Reelin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cajal–Retzius</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rgs8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Regulator of G-protein signaling 8</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rorb<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">RAR-related orphan receptor B</td>
<td align="left" colspan="1" rowspan="1" valign="top">L4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostral</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">S100a10</td>
<td align="left" colspan="1" rowspan="1" valign="top">S100 calcium binding protein A10</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5 corticospinal motor neuron</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Satb2</td>
<td align="left" colspan="1" rowspan="1" valign="top">SATB homeobox 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">CPN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sorl1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sortilin-related receptor, L(DLR class) A repeats containing</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sox5<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">SRY (sex determining region Y)-box 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tle1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–3</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tle4<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Transducin-like enhancer of split 4</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tox</td>
<td align="left" colspan="1" rowspan="1" valign="top">Thymocyte selection-associated high mobility group box</td>
<td align="left" colspan="1" rowspan="1" valign="top">L5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostromedial</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Trp73</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tumor protein p73</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cajal–Retzius</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Unc5c</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unc-5 homolog C (C. elegans)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Unc5d (Svet1)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Unc-5 homolog D (C. elegans)</td>
<td align="left" colspan="1" rowspan="1" valign="top">L2–4</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Wnt7b<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Wingless-type MMTV integration site family, member 7B</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Wscd1</td>
<td align="left" colspan="1" rowspan="1" valign="top">WSC domain containing 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rostral</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zfpm2 (FOG2)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zinc finger protein, FOG family member 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">L6</td>
<td align="left" colspan="1" rowspan="1" valign="top">All</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>*</label>
<p><italic>Genes also identified in our microarray analysis (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). CPN, callosal projection neurons; SCPN, subcerebral projection neurons</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<p>In our laboratory, we have identified more than 124 genes that are regulated by TBR1 at E16.5 (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>; Chuang et al., <xref ref-type="bibr" rid="B10">2015</xref>). The 16 region- or layer-specific genes presented in work by Bedogni et al. (<xref ref-type="bibr" rid="B1">2010</xref>) from Dr. Hevner's laboratory are also included in our gene list (Table <xref ref-type="table" rid="T2">2</xref>). Moreover, based on a literature search and the database of the Simons Foundation Autism Research Initiative (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/autdb/Welcome.do">https://gene.sfari.org/autdb/Welcome.do</ext-link>), 23 ASD-associated genes and a dyslexia causative gene, Kiaa0319, have also been found to be regulated by TBR1. Changes in the expression of these ASD- and dyslexia-associated genes (Table <xref ref-type="table" rid="T3">3</xref>) provide support for the influence of TBR1 in ASDs. Tbr1 might act as master gene controlling the expression of a panel of ASD-associated genes and thus influence neural development and function (Chuang et al., <xref ref-type="bibr" rid="B10">2015</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p><bold>TBR1 influences the expression (upregulation or downregulation) of genes associated with autism or dyslexia</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene symbol</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Molecular function</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Tbr1<sup>−∕−</sup> vs. WT</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Disease</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cd44</td>
<td align="left" colspan="1" rowspan="1" valign="top">CD44 molecule (Indian blood group)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cdh8</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cadherin 8, type 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cntn6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gpc6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glypican 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ntng1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Netrin G1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kiaa0319</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypothetical protein D130043K22</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cell adhesion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dyslexia</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nefl</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurofilament, light polypeptide</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cytoskeleton</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gpd2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glycerol-3-phosphate dehydrogenase 2 (mitochondrial)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Enzyme</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Drd1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dopamine receptor D1A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotransmission</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gad1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate decarboxylase 1 (brain, 67 kDa)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotransmission</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Grin2b</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glutamate receptor, ionotropic, N-methyl D-aspartate 2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurotransmission</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Baiap2</td>
<td align="left" colspan="1" rowspan="1" valign="top">BAI1-associated protein 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lasp1</td>
<td align="left" colspan="1" rowspan="1" valign="top">LIM and SH3 protein 1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Lypd6</td>
<td align="left" colspan="1" rowspan="1" valign="top">LY6/PLAUR domain containing 6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ppp1r1b</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein phosphatase 1, regulatory (inhibitor) subunit 1B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ptprk</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein tyrosine phosphatase, receptor type, K</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Reln</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reelin</td>
<td align="left" colspan="1" rowspan="1" valign="top">Signaling</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Auts2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism susceptibility candidate 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nfia</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear factor I/A</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nr4a2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear receptor subfamily 4, group A, member 2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sox5</td>
<td align="left" colspan="1" rowspan="1" valign="top">SRY (sex determining region Y)-box 5</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription factor</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Slc4a10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Solute carrier family 4, sodium bicarbonate transporter, member 10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transporter</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Stxbp6</td>
<td align="left" colspan="1" rowspan="1" valign="top">Syntaxin binding protein 6 (amisyn)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vesicle trafficking</td>
<td align="left" colspan="1" rowspan="1" valign="top">Up</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sv2b</td>
<td align="left" colspan="1" rowspan="1" valign="top">Synaptic vesicle glycoprotein 2B</td>
<td align="left" colspan="1" rowspan="1" valign="top">Vesicle trafficking</td>
<td align="left" colspan="1" rowspan="1" valign="top">Down</td>
<td align="left" colspan="1" rowspan="1" valign="top">Autism</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Moreover, the expression levels of 15 transcriptional regulators are reduced, while those of three transcription factors are upregulated in <italic>Tbr1</italic><sup>−∕−</sup> brains compared with wild-type littermates (Table <xref ref-type="table" rid="T4">4</xref>). These changes suggest that, in addition to directly regulating gene expression, TBR1 also controls transcriptional networks to influence neuronal development. Indeed, evidence has indicated that TBR1 directly binds to the locus of <italic>Fezf2</italic>, a layer 5-specific transcription factor, and represses <italic>Fezf2</italic> expression in layer 6 to specify the corticothalamal projections of layer 6 neurons (Han et al., <xref ref-type="bibr" rid="B21">2011</xref>; McKenna et al., <xref ref-type="bibr" rid="B38">2011</xref>). The second transcriptional regulator directly controlled by TBR1 is autistic susceptibility gene2 (<italic>Auts2</italic>). TBR1 binds to the region around the <italic>Auts2</italic> transcriptional start site and activates expression of the <italic>Auts2</italic> gene (Bedogni et al., <xref ref-type="bibr" rid="B1">2010</xref>). AUTS2 is part of polycomb repressive complex I (PRCI) that catalyzes the monoubiquitination of histone H2A and epigenetically represses gene expression, particularly during the developmental stage (de Napoles et al., <xref ref-type="bibr" rid="B12">2004</xref>; Wang et al., <xref ref-type="bibr" rid="B57">2004b</xref>). In contrast to the canonical role of PRCI in gene repression, the PRCI–AUST2 complex activates neuronal gene expression by recruiting casein kinase 2 and p300 to chromatin (Gao et al., <xref ref-type="bibr" rid="B17">2014</xref>). The activation of <italic>Auts2</italic> expression by TBR1 supports the influence of TBR1 on global gene expression in neurons.</p>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p><bold>Deletion of <italic><bold>Tbr1</bold></italic> influences the expression of a panel of transcription factors in neurons</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene Symbol</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Tbr1<sup>−∕−</sup> vs. WT</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Bcl6</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.3623</td>
<td align="left" colspan="1" rowspan="1" valign="top">B-cell leukemia/lymphoma 6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nfe2l3</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.4017</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nuclear factor, erythroid derived 2, like 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nhlh2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.4219</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nescient helix loop helix 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sox5</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.4875</td>
<td align="left" colspan="1" rowspan="1" valign="top">BB018032 RIKEN full-length enriched, adult male testis (DH10B) <italic>Mus musculus</italic> cDNA clone 4930572C18 3′ similar to AJ010604 <italic>Mus musculus</italic> mRNA for transcription factor L-Sox5, mRNA sequence.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nr4a2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.5179</td>
<td align="left" colspan="1" rowspan="1" valign="top">BB703394 RIKEN full-length enriched, <italic>in vitro</italic> fertilized eggs <italic>Mus musculus</italic> cDNA clone 7420451N07 3′, mRNA sequence.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rorb</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.529</td>
<td align="left" colspan="1" rowspan="1" valign="top">RAR-related orphan receptor beta</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tp73</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.5355</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transformation related protein 73</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Btbd11</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.5719</td>
<td align="left" colspan="1" rowspan="1" valign="top">BTB (POZ) domain containing 11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tle4</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.5821</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transducin-like enhancer of split 4, homolog of Drosophila E(spl)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Rbm14</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.59</td>
<td align="left" colspan="1" rowspan="1" valign="top">RNA binding motif protein 14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Foxf2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.5983</td>
<td align="left" colspan="1" rowspan="1" valign="top">Forkhead box F2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Tfap2c</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.6348</td>
<td align="left" colspan="1" rowspan="1" valign="top">Transcription factor AP-2, gamma</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Zswim4</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.639</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zinc finger, SWIM domain containing 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nfia</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.643</td>
<td align="left" colspan="1" rowspan="1" valign="top">RIKEN cDNA 9430022M17 gene</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurod6</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.6644</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurogenic differentiation 6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Runx1t1</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.5064</td>
<td align="left" colspan="1" rowspan="1" valign="top">CBFA2T1 identified gene homolog (human)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ascl1</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.6328</td>
<td align="left" colspan="1" rowspan="1" valign="top">Achaete–scute complex homolog-like 1 (Drosophila)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pou3f1</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.6528</td>
<td align="left" colspan="1" rowspan="1" valign="top">POU domain, class 3, transcription factor 1</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In addition to using a transcriptional cascade to indirectly control gene expression, TBR1 may also alter the relative number of projection neurons and interneurons in the brain and influence the total expression levels of certain genes, such as <italic>Gad1</italic>, which encodes glutamate decarboxylase 1 (GAD67)—an essential gene of GABAergic neurons. In <italic>Tbr1</italic> deletion mice, the expression of <italic>Gad1</italic> is noticeably upregulated (Chuang et al., <xref ref-type="bibr" rid="B10">2015</xref>). Because Tbr1 is specifically expressed in glutamatergic projection neurons, it is possible to speculate that increased <italic>Gad1</italic> expression is indirectly linked to a reduction in the population of glutamatergic neurons.</p>
<p>Consistent with the function of TBR1 in the regulation of axonal projection, TBR1 also regulates eight membrane proteins (CNTN2, CDH8, GPC6, CD44, FLRT3, CNTN6, NTNG1, and KIAA0319) that are involved in cell adhesion; although it is still unclear whether these genes are directly or indirectly regulated by TBR1 (Chuang et al., <xref ref-type="bibr" rid="B10">2015</xref>). Interestingly, seven of these eight membrane proteins are upregulated in <italic>Tbr1</italic><sup>−∕−</sup> brains (Table <xref ref-type="table" rid="T5">5</xref>). Because these genes control cell adhesion and axonal growth, the impairment of axonal projection in <italic>Tbr1</italic> deficient neurons is likely due to imbalanced cell–cell and cell–matrix interactions. Alteration of the strength of these interactions may preclude neurite growth and extension (Chuang et al., <xref ref-type="bibr" rid="B10">2015</xref>).</p>
<table-wrap id="T5" position="float">
<label>Table 5</label>
<caption>
<p><bold><italic><bold>Tbr1</bold></italic> deletion mainly upregulates expression of cell adhesion molecules in neurons</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene symbol</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Tbr1<sup>−∕−</sup> vs. WT</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene name</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cdh8</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.5013</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cadherin 8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Gpc6</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.5874</td>
<td align="left" colspan="1" rowspan="1" valign="top">Glypican 6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cd44</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.7384</td>
<td align="left" colspan="1" rowspan="1" valign="top">CD44 antigen</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Flrt3</td>
<td align="center" colspan="1" rowspan="1" valign="top">1.8118</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fibronectin leucine rich transmembrane protein 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cntn6</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.0967</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ntng1</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.3218</td>
<td align="left" colspan="1" rowspan="1" valign="top">Netrin G1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Kiaa0319</td>
<td align="center" colspan="1" rowspan="1" valign="top">2.8456</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hypothetical protein D130043K22</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Cntn2</td>
<td align="center" colspan="1" rowspan="1" valign="top">0.6331</td>
<td align="left" colspan="1" rowspan="1" valign="top">Contactin 2</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>In conclusion, TBR1 controls the expression of a series of genes that regulate cell-cell adhesion, axonal growth, neurotransmission and gene expression.</p>
</sec>
<sec id="s4">
<title>TBR1 interacting proteins</title>
<p>To date, only two proteins, CASK and FOXP2, have been identified as interacting partners with TBR1. Both CASK and FOXP2 are associated with ASDs (Samuels et al., <xref ref-type="bibr" rid="B51">2007</xref>; O'roak et al., <xref ref-type="bibr" rid="B44">2011</xref>). TBR1 was identified as a binding partner for CASK from a yeast two-hybrid screen using the guanylate kinase domain of CASK as bait (Hsueh et al., <xref ref-type="bibr" rid="B26">2000</xref>). The C-terminal region of TBR1 is required for the interaction with CASK (Hsueh et al., <xref ref-type="bibr" rid="B26">2000</xref>). CASK—a multidomain adaptor protein—is widely distributed in various subcellular compartments and interacts with more than two dozen cellular proteins (Hsueh, <xref ref-type="bibr" rid="B24">2006</xref>). The interaction with CASK increases the transcriptional activity of TBR1 (Hsueh et al., <xref ref-type="bibr" rid="B26">2000</xref>) by recruiting a nucleosome assembly protein CINAP (CASK interacting nucleosome assembly protein, also known as testis specific protein Y-encoded like 2, TSPYL2) to the promoter region containing the T-box DNA binding motif (Wang et al., <xref ref-type="bibr" rid="B56">2004a</xref>). CINAP also interacts with the guanylate kinase domain of CASK. However, it does not compete with TBR1 for CASK binding. Instead, TBR1, CASK and CINAP form a tripartite complex to regulate <italic>Grin2b</italic> expression (Wang et al., <xref ref-type="bibr" rid="B56">2004a</xref>,<xref ref-type="bibr" rid="B58">c</xref>). <italic>CASK</italic> is well-known as a causative gene in X-linked mental retardation (Najm et al., <xref ref-type="bibr" rid="B40">2008</xref>). The interaction of CASK and TBR1 and the consequent effect on the regulation of <italic>Grin2b</italic> expression and neural development has been suggested to contribute to the phenotype of patients with <italic>CASK</italic> mutations (Hsueh, <xref ref-type="bibr" rid="B25">2009</xref>). It can also be speculated that <italic>Grin2b</italic> expression, as controlled by the TBR1–CASK complex, might also be involved in ASDs due to <italic>TBR1</italic> or <italic>CASK</italic> mutations.</p>
<p>FOXP2 is a critical transcription factor that controls speech (Lai et al., <xref ref-type="bibr" rid="B32">2001</xref>; Enard et al., <xref ref-type="bibr" rid="B15">2002</xref>) and is also associated with ASDs (Gong et al., <xref ref-type="bibr" rid="B19">2004</xref>; Li et al., <xref ref-type="bibr" rid="B36">2005</xref>). In contrast to the interaction between CASK and TBR1, the interaction between TBR1 and FOXP2 is less clear. Research suggests that both the T-box and C-terminal regions of TBR1 are involved in the interaction with FOXP2 (Deriziotis et al., <xref ref-type="bibr" rid="B13">2014</xref>). For FOXP2, both its N- and C-terminal regions contribute to the interaction between FOXP2 and TBR1 (Deriziotis et al., <xref ref-type="bibr" rid="B13">2014</xref>). Although it has been speculated that the interaction of FOXP2 and TBR1 is likely relevant to the verbal deficits in ASD patients, the molecular function of the TBR1-FOXP2 interaction is unclear. Furthermore, FOXP2 and TBR1 are only coexpressed in layer 6 of the cerebral cortex and not in other layers of the cerebral cortex and amygdala. Thus, the interaction with FOXP2 can only partly account for the function of TBR1.</p>
<p>TBR1, its binding partners CASK and FOXP2 and its direct downstream target GRIN2B, are all associated with ASDs, reinforcing the role of TBR1 in ASDs.</p>
</sec>
<sec id="s5">
<title>TBR1 mutations associate with neurological disorders</title>
<p>Genetic analyses of patients have identified <italic>TBR1</italic> as a high-confidence risk factor for ASDs (<ext-link ext-link-type="uri" xlink:href="https://gene.sfari.org/autdb/GSGeneList.do?c=1">https://gene.sfari.org/autdb/GSGeneList.do?c=1</ext-link>). Identified mutations in TBR1 genes are summarized in Figure <xref ref-type="fig" rid="F1">1</xref>. Both <italic>de novo</italic> and inherited mutations in <italic>TBR1</italic> have been found in patients with ASDs (Figure <xref ref-type="fig" rid="F1">1</xref>). Two of the mutations, p.A136PfsX80 and p.S351X, result in early termination and generate truncated proteins that lack a functional DNA-binding T-box domain (O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>,<xref ref-type="bibr" rid="B46">b</xref>; De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>). These two truncated mutants can no longer function in transcription or in interactions with CASK and FOXP2. The remaining three <italic>de novo</italic> mutations are p.K228E, p.W271C, and p.N374H (Figure <xref ref-type="fig" rid="F1">1</xref>). Based on simulations with the T-box DNA binding domain of Brachury (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=250216">http://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?uid=250216</ext-link>), the K228 residue is predicted to directly contribute to DNA binding (Figure <xref ref-type="fig" rid="F1">1</xref>). Thus, the p.K228E mutation is expected to disrupt the DNA binding ability of TBR1. The residues W271 and N374 are adjacent to the DNA binding residues (Figure <xref ref-type="fig" rid="F1">1</xref>). Thus, the p.W271C and p.N374H mutations could alter protein conformation and indirectly influence DNA binding. The p.V356M inherited mutation is localized in the T-box, but it is relatively far from the DNA binding and dimerization motifs. The remaining inherited mutations, including p.E31Q, p.P38T, p.Q178E, p.Q418R, p.V437L, and p.P542R, are localized to the N- and C-terminal regions and are not known to influence DNA binding. The impact of these inherited mutations is unclear.</p>
<p>To date, only two studies have analyzed the effects of these ASD mutations on TBR1 function. We contributed to the first functional study, which examined axonal growth in the amygdalar neurons of the TBR1 N374H mutant (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). An experiment comparing <italic>Tbr1</italic><sup>+∕−</sup> and wild-type amygdalar neurons showed that the deletion of one <italic>Tbr1</italic> gene results in multiple and shorter axons in amygdalar neurons (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). The reintroduction of wild-type <italic>Tbr1</italic> into <italic>Tbr1</italic><sup>+∕−</sup> amygdalar neurons effectively promotes axon growth and reduces the percentage of neurons carrying multiple axons to the levels seen in wild-type neurons. However, the N374H mutant fails to rescue the axonal defects of <italic>Tbr1</italic><sup>+∕−</sup> amygdalar neurons, suggesting that the p.N374H mutation identified in patients with ASD results in a loss of function (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>).</p>
<p>The second study focused on the effect of ASD mutations on the subcellular distribution, transcriptional activity, dimerization and protein-protein interaction of TBR1 using heterologous HEK293 cells as a model (Deriziotis et al., <xref ref-type="bibr" rid="B13">2014</xref>). De novo mutations, including p.K228E and p.N374H, change the subcellular distribution of TBR1 in HEK293 cells. The mutant proteins tend to form large aggregates in the nuclei. The impact of these two mutations on the transcriptional activity of TBR1 is unclear because the luciferase reporter assay did not show a difference between the wild-type TBR1 and K228E and N374H mutants. However, similar to the truncated mutants, the K228E and N374H mutants no longer interact with FOXP2, which is consistent with the observation that the T-box domain is also involved in FOXP2 interactions, as described above. The mechanisms by which rare inherited mutations impair the function of TBR1 remain largely unclear, except for the p.Q418R mutation, which is known to reduce the interaction between TBR1 and FOXP2. Because TBR1 is a projection neuron-specific transcription factor, the relevance of the interaction between TBR1 and FOXP2 must be investigated in neurons instead of HEK293 cells.</p>
<p>In addition to ASDs, <italic>TBR1</italic> is also associated with intellectual disability. The <italic>TBR1</italic> locus is at chromosome 2q24.2. Both a microdeletion of the chromosome region that contains 2q24.2 and <italic>de novo</italic> mutations of the <italic>TBR1</italic> gene have been found in patients with intellectual disabilities (Traylor et al., <xref ref-type="bibr" rid="B54">2012</xref>; Burrage et al., <xref ref-type="bibr" rid="B7">2013</xref>; Hamdan et al., <xref ref-type="bibr" rid="B20">2014</xref>; Palumbo et al., <xref ref-type="bibr" rid="B47">2014</xref>). Moreover, the expression levels of TBR1 are increased in patients that suffer from schizophrenia (Molnar et al., <xref ref-type="bibr" rid="B39">2003</xref>). Taken together, TBR1 is closely associated with ASDs, schizophrenia and intellectual disability.</p>
</sec>
<sec id="s6">
<title><italic>Tbr1</italic> haploinsufficiency results in neuronal defects</title>
<p>In ASD patients, only one of the two <italic>TBR1</italic> alleles is mutated (Neale et al., <xref ref-type="bibr" rid="B42">2012</xref>; O'roak et al., <xref ref-type="bibr" rid="B45">2012a</xref>,<xref ref-type="bibr" rid="B46">b</xref>; De Rubeis et al., <xref ref-type="bibr" rid="B14">2014</xref>; Deriziotis et al., <xref ref-type="bibr" rid="B13">2014</xref>). Several possibilities may explain the effect of <italic>TBR1</italic> heterozygosity on brain function: haploinsufficiency or a dominant negative or gain-of-function effect of the mutated allele. Because two of the <italic>de novo</italic> mutations of the <italic>TBR1</italic> gene, p.A136PfsX80, and p.S351X, result in early termination and generate truncated proteins that lack a full length T-box DNA binding domain and dimerization domain (Figure <xref ref-type="fig" rid="F1">1</xref>), the mutants are not expected to exert a dominant negative effect on the activity of TBR1 based on the known molecular function of TBR1. Instead, the defects are likely caused by haploinsufficiency. <italic>Tbr1</italic><sup>+∕−</sup> neurons are characterized by shorter and multiple axons (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>), indicating that loss of a copy of the <italic>Tbr1</italic> gene results in abnormal neuronal differentiation. Thus, <italic>TBR1</italic> deficits in patients are likely due to haploinsufficiency.</p>
</sec>
<sec id="s7">
<title><italic>Tbr1<sup>+∕−</sup></italic> mice serve as a mouse model for ASDs</title>
<p>Because only one of two <italic>TBR1</italic> alleles is mutated in patients with ASDs and <italic>Tbr1</italic> heterozygosity does not influence survival and the general health of mice, <italic>Tbr1</italic><sup>+∕−</sup> mice serve as a good animal model to elucidate the role of <italic>Tbr1</italic> in ASDs. The core symptoms of patients with ASDs are both verbal and non-verbal communication defects, impaired social interaction and cognitive inflexibility. ASDs are also frequently associated with learning disability. A series of behavior paradigms have been applied to characterize the behavioral defects of <italic>Tbr1</italic> (Table <xref ref-type="table" rid="T6">6</xref>). Compared with wild-type littermates, the locomotor and exploratory activities, the level of anxiety and the hippocampus-dependent memory of <italic>Tbr1</italic><sup>+∕−</sup> mice are normal (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). However, the amygdala-dependent behaviors of <italic>Tbr1</italic><sup>+∕−</sup> mice are noticeably affected. Conditioned taste aversion and auditory fear conditioning—two amygdala-dependent learning and memory paradigms—are both impaired in <italic>Tbr1</italic><sup>+∕−</sup> mice. Cognitive flexibility, as examined by appetitive-motivated T-maze and two-choice digging tests, is also noticeably reduced in <italic>Tbr1</italic><sup>+∕−</sup> mice. The three-chamber test, reciprocal social interactions and social transmission of food preferences have also been applied to characterize the social interactions of <italic>Tbr1</italic><sup>+∕−</sup> mice. These paradigms all indicate that the social interactions of <italic>Tbr1</italic><sup>+∕−</sup> mice are impaired. Moreover, the frequency of ultrasonic vocalization is significantly lower in isolated <italic>Tbr1</italic><sup>+∕−</sup> pups. Thus, these behavioral analyses strongly support that <italic>Tbr1</italic><sup>+∕−</sup> mice exhibit autism-like behaviors (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>).</p>
<table-wrap id="T6" position="float">
<label>Table 6</label>
<caption>
<p><bold><italic><bold>Tbr1</bold></italic> haploinsufficiency results in autism-like behaviors in mice</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Behavior paradigm</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Assay for</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype in Tbr1<sup>+∕−</sup> mice</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Conditioned taste aversion</td>
<td align="left" colspan="1" rowspan="1" valign="top">Learning and memory</td>
<td align="left" colspan="1" rowspan="1" valign="top">Learning defect</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Auditory fear conditioning</td>
<td align="left" colspan="1" rowspan="1" valign="top">Learning and memory</td>
<td align="left" colspan="1" rowspan="1" valign="top">Learning defect</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">T-maze test</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reverse learning</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cognition inflexibility</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Two-choice digging task</td>
<td align="left" colspan="1" rowspan="1" valign="top">Reverse learning</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cognition inflexibility</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Three-chamber test</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Poor social interaction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Reciprocal social interactions</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Poor social interaction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Social transmission of food preference</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social interaction</td>
<td align="left" colspan="1" rowspan="1" valign="top">Poor social interaction</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ultrasonic vocalizations</td>
<td align="left" colspan="1" rowspan="1" valign="top">Communication</td>
<td align="left" colspan="1" rowspan="1" valign="top">Poor communication</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s8">
<title>Defects in amygdalar circuits and activation are critical for ASDs caused by <italic>Tbr1</italic> deficiency</title>
<p>When <italic>Tbr1</italic> is completely deleted from mice, the most prominent phenotypes are observed in the neuronal migration and axonal projection of the embryonic cerebral cortex (Bulfone et al., <xref ref-type="bibr" rid="B6">1998</xref>; Hevner et al., <xref ref-type="bibr" rid="B22">2001</xref>). However, none of these defects are found in the <italic>Tbr1</italic><sup>+∕−</sup> brain (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). Cortical lamination, contralateral cortical projection, corticothalamal projection and the size of the cerebral cortex of <italic>Tbr1</italic><sup>+∕−</sup> brains are comparable to those of wild-type brains (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). Unexpectedly, the posterior part of the anterior commissure is either missing or dramatically reduced in <italic>Tbr1</italic><sup>+∕−</sup> mice (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). This defect is 100% penetrant in all <italic>Tbr1</italic><sup>+∕−</sup> mice. Thus, the posterior part of the anterior commissure is the structure most sensitive to <italic>Tbr1</italic> haploinsufficiency. Consequently, defects of the posterior part of the anterior commissure are more relevant to the pathogenesis of <italic>TBR1</italic>-dependent ASDs.</p>
<p>The posterior part of the anterior commissure serves to connect the contralateral amygdalae (interamygdalar projections). The amygdala contains three major nuclei, namely the lateral, basal and central amygdala (Figure <xref ref-type="fig" rid="F2">2</xref>). Interamygdalar projections emerge from the lateral and basal amygdala. These two nuclei also project to the ipsilateral central amygdala (intraamygdalar projections). The lateral and basal amygdalae are the nuclei that receive inputs from the cortex, thalamus and hippocampus. To induce a freezing response, the lateral and basal amygdalae deliver the signals to the central amygdala, and the central amygdala further projects to the brainstem and hypothalamus. In addition to the central amygdala, the lateral and basal amygdalae also project back to the cortex, hippocampus, and thalamus, which are believed to regulate memory and social behavior (Lee et al., <xref ref-type="bibr" rid="B35">2013</xref>; Janak and Tye, <xref ref-type="bibr" rid="B30">2015</xref>). Because the amygdala is the pivotal brain structure for social intelligence, the amygdala is an obvious target for the etiology of <italic>TBR1</italic>-dependent ASDs.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>Neural circuits of amygdala</bold>. The relative position of lateral, basal and central amygdalae and the known axonal connections of amygdala are summarized. In lateral and basal amygdalae, glutamatergic neurons comprise the majority of cells. In contrast, GABAergic neurons are the major population in the central amygdala. Dark red lines, afferent pathways from cortex, thalamus and hippocampus; red lines, efferent pathways to contralateral amygdala, cortex and hippocampus; orange lines, intraamygdalar pathways. The central amygdala also delivers signals to the brainstem and hypothalamus to regulate freezing and emotion responses.</p>
</caption>
<graphic xlink:href="fnins-09-00406-g0002"></graphic>
</fig>
<p>The results of DiI tracing and retrograde red bead labeling show that both inter- and intra-amygdalar axonal projections are noticeably impaired in <italic>Tbr1</italic><sup>+∕−</sup> mice (Figure <xref ref-type="fig" rid="F3">3</xref>; Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). The lateral and basal amygdala neurons are the major target of Tbr1 haploinsufficiency. Consistent with the axonal projection defects in the brain, <italic>Tbr1</italic><sup>+∕−</sup> amygdala neurons possess shorter and multiple axons, which suggests that <italic>Tbr1</italic> haploinsufficiency results in a cell-autonomous effect that restricts axonal extension and differentiation (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). To investigate how TBR1 controls axonal growth, we examined the TBR1 downstream target genes in a gene list from our microarray data. Specifically, we examined <italic>Cntn2, Cdh8</italic>, and <italic>Ntng1</italic> because these three genes encode adhesion proteins that regulate neurite outgrowth and fasciculation (Furley et al., <xref ref-type="bibr" rid="B16">1990</xref>; Stoeckli and Landmesser, <xref ref-type="bibr" rid="B53">1995</xref>; Kunz et al., <xref ref-type="bibr" rid="B31">1998</xref>; Nakashiba et al., <xref ref-type="bibr" rid="B41">2002</xref>; Bekirov et al., <xref ref-type="bibr" rid="B2">2008</xref>). Restoring the expression levels of <italic>Cntn2, Cdh8</italic>, and <italic>Ntng1</italic> in <italic>Tbr1</italic><sup>+∕−</sup> amygdalar neurons effectively ameliorates axonal growth and differentiation in cultures and promotes axonal projection to form the posterior part of the anterior commissure <italic>in vivo</italic>. Thus, TBR1 controls the expression of a panel of genes that regulate amygdalar axonal projections. Note that although the axonal projections of lateral and basal amygdalae are significantly impaired in <italic>Tbr1</italic><sup>+∕−</sup> brains, the size and cell density of the lateral and basal amygdalae do not differ between <italic>Tbr1</italic><sup>+∕−</sup> mice and wild-type littermates. It is unclear whether <italic>Tbr1</italic><sup>+∕−</sup> amygdalar neurons mistarget to other brain regions. More investigations are needed to characterize this regulation in detail.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><bold><italic><bold>Tbr1</bold></italic> haploinsufficiency results in defects of intra- and inter-amygdalar axonal projections</bold>. <bold>(A)</bold> Wild-type mice. <bold>(B)</bold>
<italic>Tbr1</italic><sup>+∕−</sup> mice. <bold>(C)</bold>
<italic>Tbr1</italic><sup>+∕−</sup> mice with D-cycloserine or clioquinol injection. The interamygdalar projection via the posterior part of the anterior commissure is significantly impaired in <italic>Tbr1</italic><sup>+∕−</sup> mice. Intraamygdalar connections between basolateral and central amygdalae are also noticeably reduced in <italic>Tbr1</italic><sup>+∕−</sup> mice. <italic>Tbr1</italic><sup>+∕−</sup> mice are characterized by autism-like behaviors. Increased neuronal activity in the amygdala using either D-cycloserine or clioquinol restores behavioral defects to normal levels, although axonal projection defects are not rescued.</p>
</caption>
<graphic xlink:href="fnins-09-00406-g0003"></graphic>
</fig>
<p>Although the significance of interamygdalar connections is unclear, a reduction of intraamygdalar axonal projections implies that the amygdala is functionally impaired in <italic>Tbr1</italic><sup>+∕−</sup> mice. Indeed, neuronal activation of the amygdala is impaired in <italic>Tbr1</italic><sup>+∕−</sup> mice (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). Two amygdala-dependent learning/memory paradigms—conditioned taste aversion and auditory fear conditioning—have been used to investigate amygdalar responses. Both c-FOS and NMDAR2B protein levels were used to monitor neuronal activation in amygdalae. These experiments showed that the induction of both c-FOS and NMDAR2B are either much lower or completely absent in the lateral and basal amygdalae of <italic>Tbr1</italic><sup>+∕−</sup> mice after conditioned taste aversion training and auditory fear conditioning (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>; Chuang et al., <xref ref-type="bibr" rid="B10">2015</xref>). Thus, both axonal projection and neuronal activation are defective in <italic>Tbr1</italic><sup>+∕−</sup> amygdalae.</p>
<p>Possibly due to an impairment of NMDAR induction in the <italic>Tbr1</italic><sup>+∕−</sup> amygdala, electrophysiological recording data showed that the NMDA/AMPA ratio is noticeably lower in the thalamic-lateral amygdala synapses of <italic>Tbr1</italic><sup>+∕−</sup> brains compared with those of wild-type brains (Lee et al., <xref ref-type="bibr" rid="B34">2015b</xref>). Consistent with amygdala-specific defects in <italic>Tbr1</italic><sup>+∕−</sup> mice, the hippocampal Schaffer collateral-CA1 pyramidal synapses do not exhibit this abnormal NMDA/AMPA ratio (Lee et al., <xref ref-type="bibr" rid="B34">2015b</xref>). These electrophysiological studies clearly demonstrate a functional NMDAR deficiency in <italic>Tbr1</italic><sup>+∕−</sup> amygdalae.</p>
<p>If impairment of amygdala activation, and particularly reduced NMDAR activity, is critical for autism-like behaviors in <italic>Tbr1</italic><sup>+∕−</sup> mice, the activation of amygdalar neurons should ameliorate the behavioral defects of <italic>Tbr1</italic><sup>+∕−</sup> mice. Indeed, a bilateral local infusion of D-cycloserine (a coagonist of NMDAR) into the amygdala clearly ameliorates the reciprocal social interaction and conditioned taste aversion defects seen in <italic>Tbr1</italic><sup>+∕−</sup> mice (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). D-cycloserine applied 30 min before the behavioral assay does not influence the expression of TBR1 target genes, suggesting the behavioral effects are mediated by an acute enhancement of NMDAR transmission. Because administration of D-cycloserine to the amygdala is sufficient to ameliorate the behavioral defects of <italic>Tbr1</italic><sup>+∕−</sup> mice, the etiology of autism-like behaviors in <italic>Tbr1</italic><sup>+∕−</sup> mice very likely involves amygdala defects (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>).</p>
<p>In addition to local infusion, systemic administration of D-cycloserine via an intraperitoneal injection also effectively restores neuronal activation of the <italic>Tbr1</italic><sup>+∕−</sup> amygdala and improves social interaction, cognitive inflexibility and associative memory of <italic>Tbr1</italic><sup>+∕−</sup> mice (Huang et al., <xref ref-type="bibr" rid="B28">2014</xref>). These results indicate a potential therapeutic avenue for ASD patients possessing <italic>TBR1</italic> gene mutations. <italic>Tbr1</italic><sup>+∕−</sup> mice are not the only mouse model to have been used to demonstrate the beneficial effect of D-cycloserine. The behavioral deficits of <italic>Shank2</italic><sup>−∕−</sup>, <italic>Nlgn1</italic><sup>−∕−</sup>, and <italic>Grid1</italic><sup>−∕−</sup> mice can also be ameliorated by systemic administration of D-cycloserine. Specifically, D-cycloserine improves social interactions in both <italic>Shank2</italic><sup>−∕−</sup> and <italic>Grid1</italic><sup>−∕−</sup> mice in a three-chamber test (Won et al., <xref ref-type="bibr" rid="B59">2012</xref>; Yadav et al., <xref ref-type="bibr" rid="B60">2012</xref>). Furthermore, D-cycloserine reduces the repetitive grooming behavior of <italic>Nlgn1</italic><sup>−∕−</sup> mice (Blundell et al., <xref ref-type="bibr" rid="B4">2010</xref>). These three mutant mice all show NMDAR defects, which is consistent with the idea that NMDAR deficits are critical to the etiology of ASDs (Lee et al., <xref ref-type="bibr" rid="B33">2015a</xref>). Improving NMDAR activity can ameliorate the behavioral defects of these mutant mice.</p>
<p>To further support the NMDAR deficit hypothesis in ASDs, we recently showed that by improving NMDAR activity via the administration of clioquinol, the social defects of <italic>Tbr1</italic><sup>+∕−</sup> mice are rescued (Lee et al., <xref ref-type="bibr" rid="B34">2015b</xref>). Clioquinol is a zinc chelator and ionophore that promotes the mobilization of zinc from presynaptic vesicles to the postsynaptic site. The postsynaptic elevation of zinc activates the protein tyrosine kinase SRC and consequently enhances NMDAR activity. Systemic administration of clioquinol noticeably improves the sociability of the mutant mice in the three-chamber test. Consistent with the behavioral rescue, the defective electrophysiological responses of mutant brains are also ameliorated by clioquinol treatment. In <italic>Tbr1</italic><sup>+∕−</sup> brains, clioquinol can restore the reduced NMDA/AMPA ratio of the thalamic-lateral amygdala synapses. Clioquinol treatment also shows a beneficial effect on <italic>Shank2</italic><sup>−∕−</sup> mice. It enhances the NMDAR activity of hippocampal Schaffer collateral-CA1 pyramidal synapses in <italic>Shank2</italic><sup>−∕−</sup> mice (Lee et al., <xref ref-type="bibr" rid="B34">2015b</xref>). Even though the molecular mechanisms responsible for the NMDAR deficit differ between <italic>Tbr1</italic><sup>+∕−</sup> and <italic>Shank2</italic><sup>−∕−</sup> mice, increasing NMDAR activity via D-cycloserine or clioquinol efficiently ameliorates the behavioral defects of these two mutant mice. These data support that an NMDAR deficit is likely to be a common pathogenic mechanism of ASDs. Moreover, studies using D-cycloserine and clioquinol suggest that activation of amygdalar neurons using suitable pharmacological treatments can ameliorate the behavioral defects caused by <italic>Tbr1</italic> haploinsufficiency, even though the axonal projection defects of the <italic>Tbr1</italic><sup>+∕−</sup> amygdala cannot be rescued in adult animals.</p>
</sec>
<sec id="s9">
<title><italic>Tbr1</italic> serves as immediate early gene to control neuronal activation in mature neurons</title>
<p>Although the expression levels of <italic>Tbr1</italic> gradually decline after birth, the protein levels of TBR1 remain detectable in adult mouse brains (Hsueh et al., <xref ref-type="bibr" rid="B26">2000</xref>; Hong and Hsueh, <xref ref-type="bibr" rid="B23">2007</xref>). Based on the following scenario, TBR1 may also play a role in the adult brain. TBR1 regulates <italic>Grin2b</italic> expression (Wang et al., <xref ref-type="bibr" rid="B56">2004a</xref>), and CASK phosphorylation by protein kinase A (PKA) enhances this regulation. CASK phosphorylation increases the interaction between TBR1 and CASK and thus upregulates <italic>Grin2b</italic> promoter activity (Huang et al., <xref ref-type="bibr" rid="B27">2010</xref>). Therefore, PKA phosphorylation may increase the ability of TBR1 to influence <italic>Grin2b</italic> expression, even though the expression levels of <italic>Tbr1</italic> are lower in adult brains.</p>
<p>A study of <italic>in vitro</italic> cultured neurons unexpectedly showed that glutamate and bicuculline treatments noticeably upregulates <italic>Tbr1</italic> expression (Chuang et al., <xref ref-type="bibr" rid="B9">2014</xref>). Two to six hours after glutamate or bicuculline treatment, both the RNA and protein levels of <italic>Tbr1</italic> are obviously increased. This induction is transient. The RNA levels of <italic>Tbr1</italic> are decreased to basal levels 12 h after stimulation. This feature is shared among the cortical, hippocampal, and amygdalar neurons, although the induction of <italic>Tbr1</italic> expression is much less pronounced in hippocampal neurons (Chuang et al., <xref ref-type="bibr" rid="B9">2014</xref>). In addition to cultured neurons, behavioral stimulation also changes <italic>Tbr1</italic> expression levels in mouse brains. When conditioned taste aversion is applied to stimulate neuronal activation, similar to <italic>c-Fos</italic> induction, <italic>Tbr1</italic> RNA levels in the lateral amygdala, the insular cortex and the ventral hippocampus are also transiently increased 2 h after training (Chuang et al., <xref ref-type="bibr" rid="B9">2014</xref>). Neuronal activation also induces <italic>Grin2b</italic> expression <italic>in vitro</italic> and <italic>in vivo</italic>, but this induction occurs several hours after that of <italic>Tbr1</italic>. Moreover, deletion of <italic>Tbr1</italic> completely blocks <italic>Grin2b</italic> induction in culture (Chuang et al., <xref ref-type="bibr" rid="B9">2014</xref>). Both NMDAR and CaMKII are required to induce <italic>Tbr1</italic> expression (Figure <xref ref-type="fig" rid="F4">4</xref>). Thus, in addition to regulating axonal differentiation and neuronal migration during the early developmental stage, <italic>Tbr1</italic> also acts as an immediate early gene in response to synaptic stimulation in mature neurons, which might contribute to the etiology of <italic>TBR1</italic>-related ASDs. In particular, the cerebral cortex of <italic>Tbr1</italic><sup>+∕−</sup> mice likely exhibits defective electrophysiological responses and thus influences behaviors, even though anatomic defects of the cerebral cortex have not been identified in <italic>Tbr1</italic><sup>+∕−</sup> mice. More investigations need to be conducted to address this possibility.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p><bold>TBR1 acts as an immediate early gene to induce <italic><bold>Grin2b</bold></italic> expression during neuronal activation</bold>. Both bicuculline, an antagonist of GABA<sub>A</sub> receptors, and glutamate treatment induce <italic>Tbr1</italic> expression. Although the transcription factor (TF) required for <italic>Tbr1</italic> expression is unknown, evidence indicates that CaMKII is involved in <italic>Tbr1</italic> upregulation. TBR1 can then induce <italic>Grin2b</italic> expression to enhance the synaptic responses (adapted from Chuang et al., <xref ref-type="bibr" rid="B9">2014</xref>).</p>
</caption>
<graphic xlink:href="fnins-09-00406-g0004"></graphic>
</fig>
</sec>
<sec id="s10">
<title>Abnormal brain wiring and excitation/inhibition imbalance—two prominent models for the pathogenic mechanism of ASDs</title>
<p>Although the etiology of ASDs is heterogeneous, the two most prominent models for autism pathogenesis in the literature are abnormal brain wiring and an imbalance of neuronal activity (excitatory/inhibitory imbalance; Rubenstein and Merzenich, <xref ref-type="bibr" rid="B50">2003</xref>; Walsh et al., <xref ref-type="bibr" rid="B55">2008</xref>; Bernardinelli et al., <xref ref-type="bibr" rid="B3">2014</xref>; Cellot and Cherubini, <xref ref-type="bibr" rid="B8">2014</xref>; Deidda et al., <xref ref-type="bibr" rid="B11">2014</xref>). These two defects lead to abnormal information processing and result in autism-like behaviors. These two models are interconnected to a certain extent. During neurodevelopment, neurons must extend their axons and form synapses with their target neurons, which allows the activity of the downstream target neurons to be regulated. In the absence of correct excitatory or inhibitory inputs, the activity of target neurons will be either too low or too high. These inappropriate levels of neuronal activity result in abnormal information processing, which leads to aberrant behaviors. Moreover, the imbalanced activity of neurons also influences (either strengthens or attenuates) their connections to other neurons. When the connection is too weak, it may be eliminated, which may alter brain wiring. In the <italic>Tbr1</italic><sup>+∕−</sup> mouse model, amygdalar axonal projections are defective. Both inter- and intra-amygdalar connections are noticeably impaired. Moreover, the NMDAR activity of amygdalar neurons is also much lower in <italic>Tbr1</italic><sup>+∕−</sup> brains. Thus, <italic>Tbr1</italic><sup>+∕−</sup> brains are characterized by both abnormal brain wiring and defective neuronal activation. Further investigation is required to see whether one deficit contributes more substantially to ASD pathology.</p>
</sec>
<sec id="s11">
<title>Concluding remarks</title>
<p><italic>Tbr1</italic><sup>+∕−</sup> mice constitute the first genetic mouse model to show that defects in amygdalar circuits and activity result in autism-like behaviors. TBR1 controls the expression of a panel of genes that is associated with ASDs. TBR1 regulates axonal growth and the neuronal activation of amygdalar neurons by regulating downstream genes. Enhancing NMDAR activation with D-cycloserine and clioquinol to increase neuronal activity can ameliorate the behavioral defects of <italic>Tbr1</italic><sup>+∕−</sup> mice, although the anatomic defects caused by <italic>Tbr1</italic> haploinsufficiency are not rescued. <italic>Tbr1</italic><sup>+∕−</sup> mice thereby serve as a model to elucidate how mutation of an autism causative gene influences brain wiring and impairs neuronal activity and consequently results in autism-like behaviors. Nevertheless, several issues remain unresolved. First, why is the amygdala the brain structure most sensitive to <italic>Tbr1</italic> haploinsufficiency? Second, since <italic>Tbr1</italic><sup>+∕−</sup> amygdalar neurons do not correctly form inter- and intra-amygdalar connections, a study of the mistargeting of <italic>Tbr1</italic><sup>+∕−</sup> amygdalar axons might further illustrate the neural circuit defects caused by <italic>Tbr1</italic> haploinsufficiency. Third, although the anatomical features of the cerebral cortex of <italic>Tbr1</italic><sup>+∕−</sup> mice are normal, the electrophysiological responses of the <italic>Tbr1</italic><sup>+∕−</sup> cerebral cortex remain to be measured. Fourth, the TBR1 downstream genes have not been annotated in detail. Only four TBR1 direct target genes have so far been identified. Further work is necessary to understand the individual actions of other TBR1 downstream target genes and how their dysfunction could generate autism-like behaviors. Finally, it is unclear how TBR1 functions as a transcriptional activator in some cases but acts as a repressor in others. This phenomenon also deserves further investigation. Addressing these questions will further elucidate the roles of TBR1 in brains and potentially impact on autism research.</p>
</sec>
<sec id="s12">
<title>Author contributions</title>
<p>Both YH and TH wrote the manuscript and prepared the tables and figures.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>This work was supported by grants from Academia Sinica (AS-103-TP-B05) and the Ministry of Science and Technology (MOST 103-2321-B-001-002, 103-2321-B-001-018, and 104-2321-B-001-050) to YH. TH is supported by a Postdoctoral Fellowship from Academia Sinica.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedogni</surname><given-names>F.</given-names></name><name><surname>Hodge</surname><given-names>R. D.</given-names></name><name><surname>Elsen</surname><given-names>G. E.</given-names></name><name><surname>Nelson</surname><given-names>B. R.</given-names></name><name><surname>Daza</surname><given-names>R. A.</given-names></name><name><surname>Beyer</surname><given-names>R. P.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Tbr1 regulates regional and laminar identity of postmitotic neurons in developing neocortex</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>107</volume>, <fpage>13129</fpage>–<lpage>13134</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1002285107</pub-id><pub-id pub-id-type="pmid">20615956</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bekirov</surname><given-names>I. H.</given-names></name><name><surname>Nagy</surname><given-names>V.</given-names></name><name><surname>Svoronos</surname><given-names>A.</given-names></name><name><surname>Huntley</surname><given-names>G. W.</given-names></name><name><surname>Benson</surname><given-names>D. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Cadherin-8 and N-cadherin differentially regulate pre- and postsynaptic development of the hippocampal mossy fiber pathway</article-title>. <source/>Hippocampus
<volume>18</volume>, <fpage>349</fpage>–<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20395</pub-id><pub-id pub-id-type="pmid">18064706</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardinelli</surname><given-names>Y.</given-names></name><name><surname>Nikonenko</surname><given-names>I.</given-names></name><name><surname>Muller</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Structural plasticity: mechanisms and contribution to developmental psychiatric disorders</article-title>. <source/>Front. Neuroanat.
<volume>8</volume>:<issue>123</issue>. <pub-id pub-id-type="doi">10.3389/fnana.2014.00123</pub-id><pub-id pub-id-type="pmid">25404897</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blundell</surname><given-names>J.</given-names></name><name><surname>Blaiss</surname><given-names>C. A.</given-names></name><name><surname>Etherton</surname><given-names>M. R.</given-names></name><name><surname>Espinosa</surname><given-names>F.</given-names></name><name><surname>Tabuchi</surname><given-names>K.</given-names></name><name><surname>Walz</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Neuroligin-1 deletion results in impaired spatial memory and increased repetitive behavior</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>2115</fpage>–<lpage>2129</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4517-09.2010</pub-id><pub-id pub-id-type="pmid">20147539</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulfone</surname><given-names>A.</given-names></name><name><surname>Smiga</surname><given-names>S. M.</given-names></name><name><surname>Shimamura</surname><given-names>K.</given-names></name><name><surname>Peterson</surname><given-names>A.</given-names></name><name><surname>Puelles</surname><given-names>L.</given-names></name><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name></person-group> (<year>1995</year>). <article-title>T-brain-1: a homolog of Brachyury whose expression defines molecularly distinct domains within the cerebral cortex</article-title>. <source/>Neuron
<volume>15</volume>, <fpage>63</fpage>–<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90065-9</pub-id><pub-id pub-id-type="pmid">7619531</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulfone</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Hevner</surname><given-names>R.</given-names></name><name><surname>Anderson</surname><given-names>S.</given-names></name><name><surname>Cutforth</surname><given-names>T.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons</article-title>. <source/>Neuron
<volume>21</volume>, <fpage>1273</fpage>–<lpage>1282</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80647-9</pub-id><pub-id pub-id-type="pmid">9883721</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burrage</surname><given-names>L. C.</given-names></name><name><surname>Eble</surname><given-names>T. N.</given-names></name><name><surname>Hixson</surname><given-names>P. M.</given-names></name><name><surname>Roney</surname><given-names>E. K.</given-names></name><name><surname>Cheung</surname><given-names>S. W.</given-names></name><name><surname>Franco</surname><given-names>L. M.</given-names></name></person-group> (<year>2013</year>). <article-title>A mosaic 2q24.2 deletion narrows the critical region to a 0.4 Mb interval that includes TBR1, TANK, and PSMD14</article-title>. <source/>Am. J. Med. Genet. A
<volume>161A</volume>, <fpage>841</fpage>–<lpage>844</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35751</pub-id><pub-id pub-id-type="pmid">23444363</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cellot</surname><given-names>G.</given-names></name><name><surname>Cherubini</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>GABAergic signaling as therapeutic target for autism spectrum disorders</article-title>. <source/>Front Pediatr
<volume>2</volume>:<issue>70</issue>. <pub-id pub-id-type="doi">10.3389/fped.2014.00070</pub-id><pub-id pub-id-type="pmid">25072038</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>H. C.</given-names></name><name><surname>Huang</surname><given-names>T. N.</given-names></name><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuronal excitation upregulates Tbr1, a high-confidence risk gene of autism, mediating Grin2b expression in the adult brain</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<issue>280</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00280</pub-id><pub-id pub-id-type="pmid">25309323</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chuang</surname><given-names>H. C.</given-names></name><name><surname>Huang</surname><given-names>T. N.</given-names></name><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name></person-group> (<year>2015</year>). <article-title>T-Brain-1 - A Potential Master Regulator in Autism Spectrum Disorders</article-title>. <source/>Autism Res.
<volume>8</volume>:<fpage>412</fpage>. <pub-id pub-id-type="doi">10.1002/aur.1456</pub-id><pub-id pub-id-type="pmid">25600067</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deidda</surname><given-names>G.</given-names></name><name><surname>Bozarth</surname><given-names>I. F.</given-names></name><name><surname>Cancedda</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives</article-title>. <source/>Front. Cell. Neurosci.
<volume>8</volume>:<issue>119</issue>. <pub-id pub-id-type="doi">10.3389/fncel.2014.00119</pub-id><pub-id pub-id-type="pmid">24904277</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Napoles</surname><given-names>M.</given-names></name><name><surname>Mermoud</surname><given-names>J. E.</given-names></name><name><surname>Wakao</surname><given-names>R.</given-names></name><name><surname>Tang</surname><given-names>Y. A.</given-names></name><name><surname>Endoh</surname><given-names>M.</given-names></name><name><surname>Appanah</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Polycomb group proteins Ring1A/B link ubiquitylation of histone H2A to heritable gene silencing and X inactivation</article-title>. <source/>Dev. Cell
<volume>7</volume>, <fpage>663</fpage>–<lpage>676</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2004.10.005</pub-id><pub-id pub-id-type="pmid">15525528</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>O'roak</surname><given-names>B. J.</given-names></name><name><surname>Graham</surname><given-names>S. A.</given-names></name><name><surname>Estruch</surname><given-names>S. B.</given-names></name><name><surname>Dimitropoulou</surname><given-names>D.</given-names></name><name><surname>Bernier</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>De novo TBR1 mutations in sporadic autism disrupt protein functions</article-title>. <source/>Nat. Commun.
<volume>5</volume>, <fpage>4954</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms5954</pub-id><pub-id pub-id-type="pmid">25232744</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Rubeis</surname><given-names>S.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Goldberg</surname><given-names>A. P.</given-names></name><name><surname>Poultney</surname><given-names>C. S.</given-names></name><name><surname>Samocha</surname><given-names>K.</given-names></name><name><surname>Cicek</surname><given-names>A. E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Synaptic, transcriptional and chromatin genes disrupted in autism</article-title>. <source/>Nature
<volume>515</volume>, <fpage>209</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1038/nature13772</pub-id><pub-id pub-id-type="pmid">25363760</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enard</surname><given-names>W.</given-names></name><name><surname>Przeworski</surname><given-names>M.</given-names></name><name><surname>Fisher</surname><given-names>S. E.</given-names></name><name><surname>Lai</surname><given-names>C. S.</given-names></name><name><surname>Wiebe</surname><given-names>V.</given-names></name><name><surname>Kitano</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Molecular evolution of FOXP2, a gene involved in speech and language</article-title>. <source/>Nature
<volume>418</volume>, <fpage>869</fpage>–<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1038/nature01025</pub-id><pub-id pub-id-type="pmid">12192408</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furley</surname><given-names>A. J.</given-names></name><name><surname>Morton</surname><given-names>S. B.</given-names></name><name><surname>Manalo</surname><given-names>D.</given-names></name><name><surname>Karagogeos</surname><given-names>D.</given-names></name><name><surname>Dodd</surname><given-names>J.</given-names></name><name><surname>Jessell</surname><given-names>T. M.</given-names></name></person-group> (<year>1990</year>). <article-title>The axonal glycoprotein TAG-1 is an immunoglobulin superfamily member with neurite outgrowth-promoting activity</article-title>. <source/>Cell
<volume>61</volume>, <fpage>157</fpage>–<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(90)90223-2</pub-id><pub-id pub-id-type="pmid">2317872</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z.</given-names></name><name><surname>Lee</surname><given-names>P.</given-names></name><name><surname>Stafford</surname><given-names>J. M.</given-names></name><name><surname>von Schimmelmann</surname><given-names>M.</given-names></name><name><surname>Schaefer</surname><given-names>A.</given-names></name><name><surname>Reinberg</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>An AUTS2-Polycomb complex activates gene expression in the CNS</article-title>. <source/>Nature
<volume>516</volume>, <fpage>349</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1038/nature13921</pub-id><pub-id pub-id-type="pmid">25519132</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilman</surname><given-names>S. R.</given-names></name><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Wigler</surname><given-names>M.</given-names></name><name><surname>Vitkup</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Rare <italic>de novo</italic> variants associated with autism implicate a large functional network of genes involved in formation and function of synapses</article-title>. <source/>Neuron
<volume>70</volume>, <fpage>898</fpage>–<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.05.021</pub-id><pub-id pub-id-type="pmid">21658583</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>X.</given-names></name><name><surname>Jia</surname><given-names>M.</given-names></name><name><surname>Ruan</surname><given-names>Y.</given-names></name><name><surname>Shuang</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Association between the FOXP2 gene and autistic disorder in Chinese population</article-title>. <source/>Am. J. Med. Genet. B Neuropsychiatr. Genet.
<volume>127B</volume>, <fpage>113</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.20162</pub-id><pub-id pub-id-type="pmid">15108192</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Srour</surname><given-names>M.</given-names></name><name><surname>Capo-Chichi</surname><given-names>J. M.</given-names></name><name><surname>Daoud</surname><given-names>H.</given-names></name><name><surname>Nassif</surname><given-names>C.</given-names></name><name><surname>Patry</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title><italic>De novo</italic> mutations in moderate or severe intellectual disability</article-title>. <source/>PLoS Genet.
<volume>10</volume>:<fpage>e1004772</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1004772</pub-id><pub-id pub-id-type="pmid">25356899</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>W.</given-names></name><name><surname>Kwan</surname><given-names>K. Y.</given-names></name><name><surname>Shim</surname><given-names>S.</given-names></name><name><surname>Lam</surname><given-names>M. M.</given-names></name><name><surname>Shin</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>TBR1 directly represses Fezf2 to control the laminar origin and development of the corticospinal tract</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>108</volume>, <fpage>3041</fpage>–<lpage>3046</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1016723108</pub-id><pub-id pub-id-type="pmid">21285371</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevner</surname><given-names>R. F.</given-names></name><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Justice</surname><given-names>N.</given-names></name><name><surname>Hsueh</surname><given-names>Y.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name><name><surname>Smiga</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Tbr1 regulates differentiation of the preplate and layer 6</article-title>. <source/>Neuron
<volume>29</volume>, <fpage>353</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00211-2</pub-id><pub-id pub-id-type="pmid">11239428</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name></person-group> (<year>2007</year>). <article-title>Cytoplasmic distribution of T-box transcription factor Tbr-1 in adult rodent brain</article-title>. <source/>J. Chem. Neuroanat.
<volume>33</volume>, <fpage>124</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchemneu.2007.01.005</pub-id><pub-id pub-id-type="pmid">17329080</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name></person-group> (<year>2006</year>). <article-title>The role of the MAGUK protein CASK in neural development and synaptic function</article-title>. <source/>Curr. Med. Chem.
<volume>13</volume>, <fpage>1915</fpage>–<lpage>1927</lpage>. <pub-id pub-id-type="doi">10.2174/092986706777585040</pub-id><pub-id pub-id-type="pmid">16842202</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Calcium/calmodulin-dependent serine protein kinase and mental retardation</article-title>. <source/>Ann. Neurol.
<volume>66</volume>, <fpage>438</fpage>–<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21755</pub-id><pub-id pub-id-type="pmid">19847910</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name><name><surname>Wang</surname><given-names>T. F.</given-names></name><name><surname>Yang</surname><given-names>F. C.</given-names></name><name><surname>Sheng</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2</article-title>. <source/>Nature
<volume>404</volume>, <fpage>298</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1038/35005118</pub-id><pub-id pub-id-type="pmid">10749215</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. N.</given-names></name><name><surname>Chang</surname><given-names>H. P.</given-names></name><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name></person-group> (<year>2010</year>). <article-title>CASK phosphorylation by PKA regulates the protein-protein interactions of CASK and expression of the NMDAR2b gene</article-title>. <source/>J. Neurochem.
<volume>112</volume>, <fpage>1562</fpage>–<lpage>1573</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2010.06569.x</pub-id><pub-id pub-id-type="pmid">20067577</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>T. N.</given-names></name><name><surname>Chuang</surname><given-names>H. C.</given-names></name><name><surname>Chou</surname><given-names>W. H.</given-names></name><name><surname>Chen</surname><given-names>C. Y.</given-names></name><name><surname>Wang</surname><given-names>H. F.</given-names></name><name><surname>Chou</surname><given-names>S. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Tbr1 haploinsufficiency impairs amygdalar axonal projections and results in cognitive abnormality</article-title>. <source/>Nat. Neurosci.
<volume>17</volume>, <fpage>240</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3626</pub-id><pub-id pub-id-type="pmid">24441682</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iossifov</surname><given-names>I.</given-names></name><name><surname>O'roak</surname><given-names>B. J.</given-names></name><name><surname>Sanders</surname><given-names>S. J.</given-names></name><name><surname>Ronemus</surname><given-names>M.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The contribution of <italic>de novo</italic> coding mutations to autism spectrum disorder</article-title>. <source/>Nature
<volume>515</volume>, <fpage>216</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1038/nature13908</pub-id><pub-id pub-id-type="pmid">25363768</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janak</surname><given-names>P. H.</given-names></name><name><surname>Tye</surname><given-names>K. M.</given-names></name></person-group> (<year>2015</year>). <article-title>From circuits to behaviour in the amygdala</article-title>. <source/>Nature
<volume>517</volume>, <fpage>284</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1038/nature14188</pub-id><pub-id pub-id-type="pmid">25592533</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunz</surname><given-names>S.</given-names></name><name><surname>Spirig</surname><given-names>M.</given-names></name><name><surname>Ginsburg</surname><given-names>C.</given-names></name><name><surname>Buchstaller</surname><given-names>A.</given-names></name><name><surname>Berger</surname><given-names>P.</given-names></name><name><surname>Lanz</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Neurite fasciculation mediated by complexes of axonin-1 and Ng cell adhesion molecule</article-title>. <source/>J. Cell Biol.
<volume>143</volume>, <fpage>1673</fpage>–<lpage>1690</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.143.6.1673</pub-id><pub-id pub-id-type="pmid">9852159</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C. S.</given-names></name><name><surname>Fisher</surname><given-names>S. E.</given-names></name><name><surname>Hurst</surname><given-names>J. A.</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F.</given-names></name><name><surname>Monaco</surname><given-names>A. P.</given-names></name></person-group> (<year>2001</year>). <article-title>A forkhead-domain gene is mutated in a severe speech and language disorder</article-title>. <source/>Nature
<volume>413</volume>, <fpage>519</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1038/35097076</pub-id><pub-id pub-id-type="pmid">11586359</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E. J.</given-names></name><name><surname>Choi</surname><given-names>S. Y.</given-names></name><name><surname>Kim</surname><given-names>E.</given-names></name></person-group> (<year>2015a</year>). <article-title>NMDA receptor dysfunction in autism spectrum disorders</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>20</volume>, <fpage>8</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2014.10.007</pub-id><pub-id pub-id-type="pmid">25636159</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>E. J.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Huang</surname><given-names>T. N.</given-names></name><name><surname>Chung</surname><given-names>C.</given-names></name><name><surname>Shin</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2015b</year>). <article-title>Trans-synaptic zinc mobilization improves social interaction in two mouse models of autism through NMDAR activation</article-title>. <source/>Nat. Commun.
<volume>6</volume>, <fpage>7168</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms8168</pub-id><pub-id pub-id-type="pmid">25981743</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>S. J.</given-names></name><name><surname>Kwon</surname><given-names>O. B.</given-names></name><name><surname>Lee</surname><given-names>J. H.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name></person-group> (<year>2013</year>). <article-title>Inhibitory networks of the amygdala for emotional memory</article-title>. <source/>Front. Neural Circuits
<volume>7</volume>:<issue>129</issue>. <pub-id pub-id-type="doi">10.3389/fncir.2013.00129</pub-id><pub-id pub-id-type="pmid">23914157</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Yamagata</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Momoi</surname><given-names>M. Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Absence of causative mutations and presence of autism-related allele in FOXP2 in Japanese autistic patients</article-title>. <source/>Brain Dev.
<volume>27</volume>, <fpage>207</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2004.06.002</pub-id><pub-id pub-id-type="pmid">15737702</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Cerdeno</surname><given-names>V.</given-names></name><name><surname>Noctor</surname><given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Cajal, Retzius, and Cajal-Retzius cells</article-title>. <source/>Front. Neuroanat.
<volume>8</volume>:<issue>48</issue>. <pub-id pub-id-type="doi">10.3389/fnana.2014.00048</pub-id><pub-id pub-id-type="pmid">24987337</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKenna</surname><given-names>W. L.</given-names></name><name><surname>Betancourt</surname><given-names>J.</given-names></name><name><surname>Larkin</surname><given-names>K. A.</given-names></name><name><surname>Abrams</surname><given-names>B.</given-names></name><name><surname>Guo</surname><given-names>C.</given-names></name><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during neocortical development</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>549</fpage>–<lpage>564</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4131-10.2011</pub-id><pub-id pub-id-type="pmid">21228164</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molnar</surname><given-names>M.</given-names></name><name><surname>Potkin</surname><given-names>S. G.</given-names></name><name><surname>Bunney</surname><given-names>W. E.</given-names></name><name><surname>Jones</surname><given-names>E. G.</given-names></name></person-group> (<year>2003</year>). <article-title>MRNA expression patterns and distribution of white matter neurons in dorsolateral prefrontal cortex of depressed patients differ from those in schizophrenia patients</article-title>. <source/>Biol. Psychiatry
<volume>53</volume>, <fpage>39</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(02)01456-7</pub-id><pub-id pub-id-type="pmid">12513943</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najm</surname><given-names>J.</given-names></name><name><surname>Horn</surname><given-names>D.</given-names></name><name><surname>Wimplinger</surname><given-names>I.</given-names></name><name><surname>Golden</surname><given-names>J. A.</given-names></name><name><surname>Chizhikov</surname><given-names>V. V.</given-names></name><name><surname>Sudi</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum</article-title>. <source/>Nat. Genet.
<volume>40</volume>, <fpage>1065</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1038/ng.194</pub-id><pub-id pub-id-type="pmid">19165920</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakashiba</surname><given-names>T.</given-names></name><name><surname>Nishimura</surname><given-names>S.</given-names></name><name><surname>Ikeda</surname><given-names>T.</given-names></name><name><surname>Itohara</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Complementary expression and neurite outgrowth activity of netrin-G subfamily members</article-title>. <source/>Mech. Dev.
<volume>111</volume>, <fpage>47</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0925-4773(01)00600-1</pub-id><pub-id pub-id-type="pmid">11804778</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neale</surname><given-names>B. M.</given-names></name><name><surname>Kou</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ma'ayan</surname><given-names>A.</given-names></name><name><surname>Samocha</surname><given-names>K. E.</given-names></name><name><surname>Sabo</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Patterns and rates of exonic <italic>de novo</italic> mutations in autism spectrum disorders</article-title>. <source/>Nature
<volume>485</volume>, <fpage>242</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1038/nature11011</pub-id><pub-id pub-id-type="pmid">22495311</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohshima</surname><given-names>T.</given-names></name></person-group> (<year>2014</year>). <article-title>Neuronal migration and protein kinases</article-title>. <source/>Front. Neurosci.
<volume>8</volume>:<issue>458</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2014.00458</pub-id><pub-id pub-id-type="pmid">25628530</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'roak</surname><given-names>B. J.</given-names></name><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Schwartz</surname><given-names>J. J.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe <italic>de novo</italic> mutations</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>585</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/ng.835</pub-id><pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Fu</surname><given-names>W.</given-names></name><name><surname>Egertson</surname><given-names>J. D.</given-names></name><name><surname>Stanaway</surname><given-names>I. B.</given-names></name><name><surname>Phelps</surname><given-names>I. G.</given-names></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>. <source/>Science
<volume>338</volume>, <fpage>1619</fpage>–<lpage>1622</lpage>. <pub-id pub-id-type="doi">10.1126/science.1227764</pub-id><pub-id pub-id-type="pmid">23160955</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'roak</surname><given-names>B. J.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Karakoc</surname><given-names>E.</given-names></name><name><surname>Krumm</surname><given-names>N.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><etal></etal></person-group>. (<year>2012b</year>). <article-title>Sporadic autism exomes reveal a highly interconnected protein network of <italic>de novo</italic> mutations</article-title>. <source/>Nature
<volume>485</volume>, <fpage>246</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/nature10989</pub-id><pub-id pub-id-type="pmid">22495309</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>O.</given-names></name><name><surname>Fichera</surname><given-names>M.</given-names></name><name><surname>Palumbo</surname><given-names>P.</given-names></name><name><surname>Rizzo</surname><given-names>R.</given-names></name><name><surname>Mazzolla</surname><given-names>E.</given-names></name><name><surname>Cocuzza</surname><given-names>D. M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>TBR1 is the candidate gene for intellectual disability in patients with a 2q24.2 interstitial deletion</article-title>. <source/>Am. J. Med. Genet. A
<volume>164A</volume>, <fpage>828</fpage>–<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36363</pub-id><pub-id pub-id-type="pmid">24458984</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papaioannou</surname><given-names>V. E.</given-names></name></person-group> (<year>2014</year>). <article-title>The T-box gene family: emerging roles in development, stem cells and cancer</article-title>. <source/>Development
<volume>141</volume>, <fpage>3819</fpage>–<lpage>3833</lpage>. <pub-id pub-id-type="doi">10.1242/dev.104471</pub-id><pub-id pub-id-type="pmid">25294936</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remedios</surname><given-names>R.</given-names></name><name><surname>Huilgol</surname><given-names>D.</given-names></name><name><surname>Saha</surname><given-names>B.</given-names></name><name><surname>Hari</surname><given-names>P.</given-names></name><name><surname>Bhatnagar</surname><given-names>L.</given-names></name><name><surname>Kowalczyk</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>A stream of cells migrating from the caudal telencephalon reveals a link between the amygdala and neocortex</article-title>. <source/>Nat. Neurosci.
<volume>10</volume>, <fpage>1141</fpage>–<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.1038/nn1955</pub-id><pub-id pub-id-type="pmid">17694053</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name><name><surname>Merzenich</surname><given-names>M. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems</article-title>. <source/>Genes Brain Behav.
<volume>2</volume>, <fpage>255</fpage>–<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1034/j.1601-183X.2003.00037.x</pub-id><pub-id pub-id-type="pmid">14606691</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samuels</surname><given-names>B. A.</given-names></name><name><surname>Hsueh</surname><given-names>Y. P.</given-names></name><name><surname>Shu</surname><given-names>T.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Tseng</surname><given-names>H. C.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK</article-title>. <source/>Neuron
<volume>56</volume>, <fpage>823</fpage>–<lpage>837</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2007.09.035</pub-id><pub-id pub-id-type="pmid">18054859</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekine</surname><given-names>K.</given-names></name><name><surname>Kubo</surname><given-names>K.</given-names></name><name><surname>Nakajima</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>How does Reelin control neuronal migration and layer formation in the developing mammalian neocortex?</article-title>
<source/>Neurosci. Res.
<volume>86</volume>, <fpage>50</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1016/j.neures.2014.06.004</pub-id><pub-id pub-id-type="pmid">24969097</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeckli</surname><given-names>E. T.</given-names></name><name><surname>Landmesser</surname><given-names>L. T.</given-names></name></person-group> (<year>1995</year>). <article-title>Axonin-1, Nr-CAM, and Ng-CAM play different roles in the <italic>in vivo</italic> guidance of chick commissural neurons</article-title>. <source/>Neuron
<volume>14</volume>, <fpage>1165</fpage>–<lpage>1179</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90264-3</pub-id><pub-id pub-id-type="pmid">7541632</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traylor</surname><given-names>R. N.</given-names></name><name><surname>Dobyns</surname><given-names>W. B.</given-names></name><name><surname>Rosenfeld</surname><given-names>J. A.</given-names></name><name><surname>Wheeler</surname><given-names>P.</given-names></name><name><surname>Spence</surname><given-names>J. E.</given-names></name><name><surname>Bandholz</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Investigation of TBR1 hemizygosity: four individuals with 2q24 microdeletions</article-title>. <source/>Mol. Syndromol.
<volume>3</volume>, <fpage>102</fpage>–<lpage>112</lpage>. <pub-id pub-id-type="doi">10.1159/000342008</pub-id><pub-id pub-id-type="pmid">23112752</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname><given-names>C. A.</given-names></name><name><surname>Morrow</surname><given-names>E. M.</given-names></name><name><surname>Rubenstein</surname><given-names>J. L.</given-names></name></person-group> (<year>2008</year>). <article-title>Autism and brain development</article-title>. <source/>Cell
<volume>135</volume>, <fpage>396</fpage>–<lpage>400</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2008.10.015</pub-id><pub-id pub-id-type="pmid">18984148</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G. S.</given-names></name><name><surname>Hong</surname><given-names>C. J.</given-names></name><name><surname>Yen</surname><given-names>T. Y.</given-names></name><name><surname>Huang</surname><given-names>H. Y.</given-names></name><name><surname>Ou</surname><given-names>Y.</given-names></name><name><surname>Huang</surname><given-names>T. N.</given-names></name><etal></etal></person-group>. (<year>2004a</year>). <article-title>Transcriptional modification by a CASK-interacting nucleosome assembly protein</article-title>. <source/>Neuron
<volume>42</volume>, <fpage>113</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(04)00139-4</pub-id><pub-id pub-id-type="pmid">15066269</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H.</given-names></name><name><surname>Vidal</surname><given-names>M.</given-names></name><name><surname>Tempst</surname><given-names>P.</given-names></name><name><surname>Jones</surname><given-names>R. S.</given-names></name><etal></etal></person-group>. (<year>2004b</year>). <article-title>Role of histone H2A ubiquitination in Polycomb silencing</article-title>. <source/>Nature
<volume>431</volume>, <fpage>873</fpage>–<lpage>878</lpage>. <pub-id pub-id-type="doi">10.1038/nature02985</pub-id><pub-id pub-id-type="pmid">15386022</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>T. F.</given-names></name><name><surname>Ding</surname><given-names>C. N.</given-names></name><name><surname>Wang</surname><given-names>G. S.</given-names></name><name><surname>Luo</surname><given-names>S. C.</given-names></name><name><surname>Lin</surname><given-names>Y. L.</given-names></name><name><surname>Ruan</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2004c</year>). <article-title>Identification of Tbr-1/CASK complex target genes in neurons</article-title>. <source/>J. Neurochem.
<volume>91</volume>, <fpage>1483</fpage>–<lpage>1492</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02845.x</pub-id><pub-id pub-id-type="pmid">15584924</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Won</surname><given-names>H.</given-names></name><name><surname>Lee</surname><given-names>H. R.</given-names></name><name><surname>Gee</surname><given-names>H. Y.</given-names></name><name><surname>Mah</surname><given-names>W.</given-names></name><name><surname>Kim</surname><given-names>J. I.</given-names></name><name><surname>Lee</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function</article-title>. <source/>Nature
<volume>486</volume>, <fpage>261</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1038/nature11208</pub-id><pub-id pub-id-type="pmid">22699620</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>S. C.</given-names></name><name><surname>Hillman</surname><given-names>B. G.</given-names></name><name><surname>Bhatt</surname><given-names>J. M.</given-names></name><name><surname>Stairs</surname><given-names>D. J.</given-names></name><name><surname>Dravid</surname><given-names>S. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Deletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviors</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e32969</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0032969</pub-id><pub-id pub-id-type="pmid">22412961</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>